Black Patients With Lymphomatoid Papulosis
Lymphomatoid papulosis (LyP) is a CD30+ T-cell lymphoproliferative disorder (LPD) presenting as a recurrent eruption of papules and nodules which resolve spontaneously. CD30+ LPD prevalence in African American (AA)/Black patients is lower compared to White patients. CD30+ LPD has been recently reported to have worse outcomes in AA patients compared to White patients.
A retrospective chart revie …
Lymphomatoid papulosis (LyP) is a CD30+ T-cell lymphoproliferative disorder (LPD) presenting as a recurrent eruption of papules and nodules which resolve spontaneously. CD30+ LPD prevalence in African American (AA)/Black patients is lower compared to White patients. CD30+ LPD has been recently reported to have worse outcomes in AA patients compared to White patients.
A retrospective chart revie … Continue reading "Black Patients With Lymphomatoid Papulosis"
The fusion of technology and medicine has led to the advent of advanced wound healing techniques that may be adapted to the management of surgical defects. Shortened duration of healing and ease-of-use are two potential benefits under investigation. Here, Matthew J. Lin MD, Danielle P. Dubin BA, Aaron S. Farberg MD, Hooman Khorasani MD, David A. Kriegel MD describe a 65-year-old male with a nasal … 
Reflectance Confocal Microscopy (RCM) is a new noninvasive skin imaging modality that is comparable to traditional histopathology. Authors Radhika Srivastava BA, Catherine Reilly BS, Gina Francisco MBS, Hamza Bhatti DO, and Babar K. Rao MD present serial in vivo RCM imaging of an atypical nevus after shave excision over a 1-month period. Findings on RCM images are consistent with the inflammatory, … 
Authors Julie K. Nguyen MD, Silvia Mancebo MD, Brady Bleicher MD, and Jared Jagdeo MD MS present a case report of a patient with localized porokeratosis lesions on the face and extremities. Brought to you by the Journal of Drugs in Dermatology, a product of SanovaWorks.
Introduction
Porokeratosis is a disorder of epidermal keratinization that encompasses multiple clinical variants based on d … 
Abstract
Botulinum toxin type A (BTA) is a neurotoxic protein that prevents the release of neurotransmitters from presynaptic nerves and has shown promise in treating neuropathic pain. Recently, BTA has been used to treat painful keloids and scars. We present a patient with refractory neuropathic pain in a normotrophic spread-scar treated with the injection of BTA.
A 47-year-old Caucasian female …